The mechanism of anti-tumor immunity induced by varlilumab, a CD27 agonist mAb, is model dependent. (4th November 2015) - He, Li-Zhen; Wasiuk, Anna; Testa, James; Weidlick, Jeffrey; Sisson, Crsytal; Crocker, Andrea; Widger, Jenifer; Forsberg, Eirc; Gergel, Lauren; Thomas, Lawrence; Marsh, Henry; Keler, Tibor